文献速递腹部技术与安全CT

基于肿瘤与内脏脂肪CT特征的深度学习模型预测浆膜侵犯胃癌根治术后腹膜转移风险

Deep Learning Model Based on Tumor and Visceral Adipose Tissue CT Features for Predicting Peritoneal Metastasis Risk after Radical Gastrectomy in Serosa-Invasive Gastric Cancer.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

该多中心回顾性研究纳入416例病理确诊浆膜侵犯胃癌患者,术前CT分割肿瘤与内脏脂肪区域并用ResNet18提取深度特征,构建融合肿瘤-VAT深度学习标签及多模态深度学习放射组学模型。MDLR在内外部测试集AUC均为0.86,显著优于临床及纯深度学习模型,高风险组无复发生存期显著缩短。

要点

  • 术前CT肿瘤与内脏脂肪联合深度学习特征可无创预测浆膜侵犯胃癌术后腹膜转移风险。
  • 融合临床指标的多模态模型MDLR预测性能最强,内外验证AUC均为0.86。
  • MDLR识别的术后高风险组无复发生存期显著更短,有助于术后风险分层。

核心结论

  • 融合肿瘤与内脏脂肪CT特征及临床指标的多模态深度学习模型可无创预测浆膜侵犯胃癌术后腹膜转移风险,并辅助术后风险分层。

研究设计与样本

  • 多中心回顾性研究,纳入2008年4月至2018年1月病理确诊的浆膜侵犯胃癌患者416例(平均年龄56.6岁±11.6,男性66.1%)。
  • 患者分为训练集、内部测试集与独立外部测试集,术前CT分割肿瘤与内脏脂肪区域,采用ResNet18网络提取深度特征。
  • 构建融合肿瘤-VAT深度学习标签(F-DLS),并用稀疏贝叶斯极限学习机将临床变量纳入多模态深度学习放射组学模型(MDLR)。
  • 采用ROC曲线、综合判别改善指数、校准曲线、决策曲线分析及无复发生存期评估模型性能。

诊断标准与关键数值

  • F-DLS预测腹膜转移的AUC在内部测试集为0.81(95%CI:0.73,0.88),外部测试集为0.79(95%CI:0.71,0.86)。
  • F-DLS的AUC数值上高于单纯肿瘤组织DLS和VAT-DLS,但差异无统计学意义。
  • MDLR预测性能最强,内部测试集AUC为0.86(95%CI:0.79,0.92),外部测试集AUC为0.86(95%CI:0.78,0.92)。
  • MDLR显著优于临床模型和纯深度学习模型(综合判别改善指数,P < .001),校准良好,决策曲线分析显示有利的净获益。
  • MDLR识别的高风险患者无复发生存期显著缩短(log-rank P < .001)。

临床应用与阅片要点

  • 阅片时可关注术前CT肿瘤区域及内脏脂肪区域的影像特征,两者联合提取的深度学习标签有助于评估腹膜转移风险。
  • 将临床指标与肿瘤-VAT深度学习特征整合可提升预测性能,报告时可提示多模态模型在术后风险分层中的潜在价值。

局限性

  • 本研究为回顾性设计,可能存在选择偏倚。
  • F-DLS与肿瘤组织DLS、VAT-DLS的AUC差异无统计学意义,联合特征的增量价值需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop and validate a deep learning model integrating tumor and visceral adipose tissue (VAT) CT scan features with clinical indicators to predict postoperative peritoneal metastasis in serosa-invasive gastric cancer. Materials and Methods This multicenter, retrospective study between April 2008 and January 2018 included patients with pathologically confirmed serosa-invasive gastric cancer. Patients were divided into training, internal test, and independent external test sets. Tumor and VAT regions were segmented at preoperative CT. Deep features were extracted using a ResNet18 network. A fused tumor-VAT deep learning signature (F-DLS) was generated, incorporating clinical variables into a multimodal deep learning radiomics model (MDLR) using a sparse Bayesian extreme learning machine. Model performance was assessed using receiver operating characteristic curve, integrated discrimination improvement, calibration, decision curve analysis, and recurrence-free survival. Results Among 416 patients (mean age, 56.6 years ± 11.6; 66.1% male patients), the F-DLS achieved area under the receiver operating characteristic curve (AUC) values of 0.81 (95% CI: 0.73, 0.88) in the internal test set and 0.79 (95% CI: 0.71, 0.86) in the external test set. Compared with the tumor tissue DLS and VAT-DLS, the F-DLS showed numerically higher AUCs without statistical significance. The MDLR achieved the strongest predictive performance, with AUCs of 0.86 (95% CI: 0.79, 0.92) in the internal test set and 0.86 (95% CI: 0.78, 0.92) in the external test set. The MDLR statistically significantly outperformed clinical and deep learning-only models (integrated discrimination improvement, P < .001), showed good calibration, and provided favorable net benefit on decision curve analysis. High-risk patients identified by the MDLR had significantly shorter recurrence-free survival (log-rank P < .001). Conclusion The MDLR integrating CT scan features and clinical indicators enabled noninvasive prediction of peritoneal metastasis risk in serosa-invasive gastric cancer and may facilitate postoperative risk stratification. Keywords: Gastric Cancer, Peritoneal Metastasis, CT, Visceral Adipose Tissue, Deep Learning Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Li Y, Wang X, Chen Q, et al. Deep Learning Model Based on Tumor and Visceral Adipose Tissue CT Features for Predicting Peritoneal Metastasis Risk after Radical Gastrectomy in Serosa-Invasive Gastric Cancer. Radiol Imaging Cancer. 2026. PMID: 42029163. doi:10.1148/rycan.250353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。